Baird analyst Michael Ha raised the firm’s price target on Cigna (CI) to $372 from $364 and keeps an Outperform rating on the shares. The firm adjusted the price target after updating its power rankings in managed care and healthcare facilities.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Judges reject 2 cases challenging Medicare negotiation, The Hill reports
- 3 Best Stocks to Buy Now, 8/8/2025, According to Top Analysts
- Cigna price target raised to $415 from $372 at Deutsche Bank
- Guggenheim trims Cigna price target, calls magnitude of weakness ‘unjustified’
- Cigna’s Mixed Performance and Valuation Concerns Justify Hold Rating